Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0.

CONCLUSIONS: A ≥1-grade improvement in persistent erythema achieved after the first dose of once-daily topical oxymetazoline demonstrated clinically meaningful improvement from the beginning of therapy. J Drugs Dermatol. 2018;17(6):621-626.
PMID: 29879249 [PubMed - in process]

Source: Journal of Drugs in Dermatology - June 9, 2018 Category: Dermatology Tags: J Drugs Dermatol Source Type: research